Santiago Arroyo

Directeur/Membre du Conseil chez H. LUNDBECK A/S

Fortune : 878 280 $ au 30/04/2024

64 ans

100 relations

Health Technology

Consumer Services

Commercial Services

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Alistair Milnes	M	50	BICYCLE THERAPEUTICS PLC	3 ans
Dominique Sirena	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Amir Faridmoayer	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Ganesh Venkataraman Kaundinya	M	57	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	4 ans
Michael Skynner	M	55	BICYCLE THERAPEUTICS PLC PFIZER, INC.	11 ans
Jose-Carlos Gutiérrez-Ramos	M	61	BICYCLE THERAPEUTICS PLC PFIZER, INC.	9 ans
Kevin Lee	M	55	BICYCLE THERAPEUTICS PLC PFIZER, INC.	12 ans
Lars Søren Rasmussen	M	65	H. LUNDBECK A/S	11 ans
Travis Thompson	M	-	BICYCLE THERAPEUTICS PLC	6 ans
Helen Hobbs	M	71	PFIZER, INC.	13 ans
Stephen Sands	M	67	BICYCLE THERAPEUTICS PLC	-
Jeremy Levin	M	70	H. LUNDBECK A/S	7 ans
Jeffrey Berkowitz	M	58	H. LUNDBECK A/S	6 ans
Gregory Winter	M	73	BICYCLE THERAPEUTICS PLC	15 ans
Lene Skole-Sørensen	F	65	H. LUNDBECK A/S	9 ans
Joseph Echevarria	M	66	PFIZER, INC.	9 ans
Jim Smith	M	64	PFIZER, INC.	10 ans
Lars Erik Holmqvist	M	64	H. LUNDBECK A/S	9 ans
Janice Bourque	F	67	BICYCLE THERAPEUTICS PLC	5 ans
Lars Bang	M	61	H. LUNDBECK A/S	36 ans
Shantanu Narayen	M	60	PFIZER, INC.	11 ans
Richard Kender	M	68	BICYCLE THERAPEUTICS PLC	5 ans
Dorothea Wenzel	M	55	H. LUNDBECK A/S	3 ans
Charl van Zyl	M	57	H. LUNDBECK A/S	1 ans
Dorte Clausen	F	40	H. LUNDBECK A/S	2 ans
Hossein Armandi	M	62	H. LUNDBECK A/S	2 ans
Camilla Andersson	F	52	H. LUNDBECK A/S	2 ans
Thomas Mikkel Mortensen	M	-	H. LUNDBECK A/S	-
Denis Patrick	M	-	PFIZER, INC.	14 ans
Lasse Skibsbye	M	41	H. LUNDBECK A/S	2 ans
David Borah	M	-	BICYCLE THERAPEUTICS PLC	3 ans
James Sutcliffe	M	68	BICYCLE THERAPEUTICS PLC	1 ans
Thomas Edward Gibbs	M	53	H. LUNDBECK A/S	1 ans
Steve Danehy	M	-	PFIZER, INC.	12 ans
Tarek Samad	M	-	H. LUNDBECK A/S	3 ans
Jennifer Perry	F	-	BICYCLE THERAPEUTICS PLC	-
Sonya Weigle	F	-	MARINUS PHARMACEUTICALS, INC.	3 ans
Zafar Qadir	M	-	BICYCLE THERAPEUTICS PLC	4 ans
Johan Luthman	M	65	H. LUNDBECK A/S	5 ans
Pierre Legault	M	63	BICYCLE THERAPEUTICS PLC	5 ans
Nicholas Keen	M	56	BICYCLE THERAPEUTICS PLC	7 ans
Keld Flintholm Jørgensen	M	53	H. LUNDBECK A/S	5 ans
Philippe Dro	M	61	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	2 ans
Mira Chaurushiya	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Jörg Hornstein	M	47	H. LUNDBECK A/S	2 ans
Palle Holm Olesen	M	-	H. LUNDBECK A/S	-
Ivan Cheung	M	47	EISAI CO., LTD.	19 ans
Juliane Lenzner	F	-	H. LUNDBECK A/S	-
Jakob Riis	M	58	H. LUNDBECK A/S	1 ans
Alethia Young	F	45	BICYCLE THERAPEUTICS PLC	1 ans
Kush Parmar	M	42	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	2 ans
Monique Schiersing	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Graziano Seghezzi	M	55	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Nigel Crockett	M	59	BICYCLE THERAPEUTICS PLC	5 ans
Georges Gemayel	M	64	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	2 ans

Graphique Relationnel

Relation dans plusieurs entreprises

Anciennes relations

Nom	Sexe	Age	Sociétés liées	Collaboration
Jeffrey Kindler	M	68	PFIZER, INC.	8 ans
William Steere	M	87	PFIZER, INC.	28 ans
Deborah Dunsire	M	61	H. LUNDBECK A/S	5 ans
Amy Schulman	F	63	PFIZER, INC.	6 ans
George A. Lorch	M	82	PFIZER, INC.	15 ans
Lee Kalowski	M	43	BICYCLE THERAPEUTICS PLC	6 ans
Michael Dougherty	M	66	MARINUS PHARMACEUTICALS, INC.	5 ans
Robert Landry	M	60	PFIZER, INC.	4 ans
Yi Ning Zhao	M	53	PFIZER, INC.	8 ans
Elise Hauge	F	57	H. LUNDBECK A/S	4 ans
Everett Cunningham	M	57	PFIZER, INC.	9 ans
John Mascotte	M	84	PFIZER, INC.	4 ans
Marc Tessier-Lavigne	M	64	PFIZER, INC.	4 ans
Jacob Tolstrup	M	52	H. LUNDBECK A/S	25 ans
Anders Götzsche	M	56	H. LUNDBECK A/S	15 ans
Shinji Hatta	M	-	EISAI CO., LTD.	4 ans
Veronica Jordan	M	73	BICYCLE THERAPEUTICS PLC	5 ans
Michael Brown	M	82	PFIZER, INC.	16 ans
Olivier Brandicourt	M	68	PFIZER, INC.	13 ans
Robert N. Burt	M	86	PFIZER, INC.	11 ans
William Herbert Gray	M	82	PFIZER, INC.	13 ans
M. Anthony Burns	M	81	PFIZER, INC.	25 ans
Nicole Vitullo	F	66	MARINUS PHARMACEUTICALS, INC.	17 ans
Alan Mendelsohn	M	62	PFIZER, INC.	2 ans
Baiyong Li	M	56	PFIZER, INC.	12 ans
David Peritt	M	60	PFIZER, INC.	1 ans
Margaret Marshall	M	67	PFIZER, INC.	8 ans
Soma Gupta	F	-	PFIZER, INC.	6 ans
Barry Ticho	M	64	PFIZER, INC.	3 ans
Venkat Reddy	M	-	PFIZER, INC.	2 ans
Premal Patel	M	54	PFIZER, INC.	2 ans
Brian Krex	M	57	PFIZER, INC.	9 ans
Carl Morris	M	54	PFIZER, INC.	5 ans
Valerie Start	M	64	PFIZER, INC.	3 ans
Margaret McLoughlin	M	61	PFIZER, INC.	5 ans
William C. Kennally	M	67	PFIZER, INC.	5 ans
Ronald Shazer	M	56	PFIZER, INC.	1 ans
Dieter Weinand	M	63	PFIZER, INC.	3 ans
John Paolini	M	59	PFIZER, INC.	1 ans
Charles Baum	M	65	PFIZER, INC.	9 ans
David Roblin	M	57	PFIZER, INC.	3 ans
Adele Gulfo	F	61	PFIZER, INC.	5 ans
Martine George	M	76	PFIZER, INC.	5 ans
Vatnak Vat-Ho	M	-	PFIZER, INC.	4 ans
Leanna Bautista	F	41	PFIZER, INC.	1 ans

Statistiques

Pays	Relations	% du total
Etats-Unis	48	48,00%
Danemark	25	25,00%
Royaume-Uni	19	19,00%
Suisse	9	9,00%
Japon	2	2,00%

Age des relations

Actives

Passées

Homme

Femme

Administrateurs

Exécutifs

Provenance des relations

Bourse
Insiders
Santiago Arroyo
Réseau Personnel